Clinical Trials Browser

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

NCT01374841 2023-06-28

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

Phase 2 Unknown

20 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT00051311 2021-09-09

Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers

Phase 2 Completed

62 enrolled 15 charts

LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT00741455 2020-11-23

Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies

Phase NA Completed

18 enrolled 7 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00506948 2020-09-24

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

Phase 2 Terminated

13 enrolled 5 charts

LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Hematologic Neoplasms

NCT01010217 2020-03-25

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Phase 2 Completed

176 enrolled 18 charts

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00176839 2017-12-05

Stem Cell Transplantation for Hematological Malignancies

Phase 2/3 Terminated

11 enrolled 12 charts

LymphoidOther hematologic neoplasm

Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00914849 2017-05-17

Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies

Phase 2 Completed

68 enrolled 16 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT00763490 2016-12-23

Trial Of Double Umbilical Cord Blood Transplantation

Phase 2 Completed

20 enrolled 9 charts

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT00058825 2016-11-07

HIMSUM

Phase 1/2 Terminated

27 enrolled 13 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT02193399 2014-08-29

TRAS

Phase NA Unknown

30 enrolled

Other hematologic neoplasm

Fatigue, Neoplasms, Hematologic Neoplasms

NCT00312429 2012-04-03

Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer

Phase 1/2 Completed

34 enrolled

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT00146614 2012-03-08

Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation

Phase 2 Completed

105 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

NCT00382759 2009-08-03

Nonmyeloablative Stem Cell Transplant in Elderly

Phase 2/3 Completed

50 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

Clinical Trials

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies

A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers

Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Stem Cell Transplantation for Hematological Malignancies

Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies

Trial Of Double Umbilical Cord Blood Transplantation

HIMSUM

TRAS

Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer

Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation

Nonmyeloablative Stem Cell Transplant in Elderly